Anavex Life Sciences Corp (AVXL)

[falconer66a]

New Anavex Drug Patent — What else?

Well, Anavex filed for a new patent; to treat the seizures of epilepsy. How could this have happened?

Only by actually conducting experiments and studies of murines (lab rodents) utilizing Anavex’s proprietary molecules A19-144 and A2-73 (also known as blarcamesine).

Understand, Anavex simply is not revealing what the company is actually working on, with new molecules or new applications and indications for those molecules. All sorts of innovative experimentation going on at Anavex. Because of these closed-door studies, Anavex knows the deep extent and broad range of results their new drugs will yield in new therapies; for a widening diversity of indications.

In five years, the Anavex story will not be only blarcamesine for Rett and Alzheimer’s. Lots, lots more....